Ribavirin aerosol for acute bronchiolitis
Abstract
A randomised double blind placebo controlled trial of treatment with an aerosolised antiviral agent, ribavirin, was conducted in 26 infants with clinically diagnosed bronchiolitis. Nebulised ribavirin (14 infants) or normal saline aerosol (12 infants) was given for 18 hours a day for at least three …
Keywords
National Center for Biotechnology Information
NCBI
NLM
MEDLINE
clinical trials as topic
humans
pubmed abstract
nih
national institutes of health
national library of medicine
research support
non-u.s. gov't
female
male
Infant
newborn
Clinical Trial
Randomized Controlled Trial
Double-Blind Method
Random Allocation
acute disease
bronchiolitis
aerosols
viral / drug therapy*
ribavirin / administration & dosage
ribavirin / therapeutic use*
respiratory syncytial viruses
pmid:3524473
pmc1777824
doi:10.1136/adc.61.6.593
w barry
f cockburn
a vardag
respirovirus infections / drug therapy*
ribonucleosides / therapeutic use*
Access
Citation
ID:
112215
References
Blockchain Verification
Account:
NFT Contract Address:
0x95644003c57E6F55A65596E3D9Eac6813e3566dA
Article ID:
112215
Unique Identifier:
Network:
Scimatic Chain (ID: 481)
Loading...
Blockchain Readiness Checklist
Authors
Abstract
Journal Name
Year
Title
Creates 1,000,000 NFT tokens for this article
Token Features:
- ERC-1155 Standard NFT
- 1 Million Supply per Article
- Transferable via MetaMask
- Permanent Blockchain Record
Scan with Saymatik Web3.0 Wallet
